An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC)

被引:56
作者
Birch, MR
Learmont, JC
Dyer, WB
Deacon, NJ
Zaunders, JJ
Saksena, N
Cunningham, AL
Mills, J
Sullivan, JS
机构
[1] Australian Red Cross Blood Serv NSW, HIV Epidemiol Res Unit, Sydney, NSW 2000, Australia
[2] Australian Red Cross Blood Serv NSW, Viral Res Lab, Tissue Typing Dept, Sydney, NSW 2000, Australia
[3] Australian Natl Ctr HIV Virol Res, Macfarlane Burnet Ctr Med Res, Fairfield, Vic 3078, Australia
[4] St Vincents Hosp, Ctr Immunol, Darlinghurst, NSW 2010, Australia
[5] Westmead Hosp, Westmead Millennium Inst, Westmead, NSW 2145, Australia
关键词
Sydney Blood Bank Cohort; long-term non-progressors; HIV-1; nef/LTR;
D O I
10.1016/S1386-6532(01)00198-6
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: The Sydney Blood Bank Cohort (SBBC) was infected between 1981 and 1984 with a nef/LTR defective strain of HIV-1. Different responses to HIV-1 infection have emerged between cohort members in the last 5 years. Three recipients (C135, C64 and C49) remain asymptomatic, have normal CD4 T cell counts, below detection (BD) viral loads (VL), remain therapy naive and are termed long-term non-progressors (LTNP). The donor (D36) and the two recipients (C98 and C54) have significantly declining CD4 T cell counts, detectable VL and are now long-term survivors (LTS). In contrast, in the SA cohort, comparison study group for the SBBC, five of 24 remain therapy naive after 15 years infection with HIV-1 and all have detectable VL. Objectives: This paper examines different outcomes to long-term infection with HIV-1 in the SBBC and provides a brief overview of the therapy naive in a comparison study group, the SA cohort. Study design: Retrospective epidemiological follow-up of the SBBC and the SA cohort has been conducted for > 15 years. Analysis of CD4 T cell counts, VL and intermittent monitoring of HIV-specific proliferative responses are reviewed. Viral sequence changes in the SBBC will be considered. Results: Prior to therapy D36 had a CD4 T cell count of 160/mm(3) and plasma VL of 9900 copies/ml while C98 had a CD4 T cell count of 387/mm(3) and plasma VL of 11 491 copies/ml. After 1 month of therapy, plasma VL was BD ( < 400 copies/ml) and both showed significant increase in CD4 T cell counts. Molecular changes have occurred in D36 and C98 viral strains, the most recently evolved quasispecies have larger deletions in the nef/LTR region. Conclusions: Infection with nef/LTR deleted HIV-1 has resulted in slower disease progression for the SBBC. The three LTNP have maintained normal low levels of activated CD8 T cells and strong HIV-specific proliferative responses to HIV-1 p24, which are associated with control of viral replication. (C) 2001 Elsevier Science BN. All rights reserved.
引用
收藏
页码:263 / 270
页数:8
相关论文
共 12 条
  • [1] CARLOS J, 2000, J VIROL, V74, P2023
  • [2] GENOMIC STRUCTURE OF AN ATTENUATED QUASI-SPECIES OF HIV-1 FROM A BLOOD-TRANSFUSION DONOR AND RECIPIENTS
    DEACON, NJ
    TSYKIN, A
    SOLOMON, A
    SMITH, K
    LUDFORDMENTING, M
    HOOKER, DJ
    MCPHEE, DA
    GREENWAY, AL
    ELLETT, A
    CHATFIELD, C
    LAWSON, VA
    CROWE, S
    MAERZ, A
    SONZA, S
    LEARMONT, J
    SULLIVAN, JS
    CUNNINGHAM, A
    DWYER, D
    DOWTON, D
    MILLS, J
    [J]. SCIENCE, 1995, 270 (5238) : 988 - 991
  • [3] DEACON NJ, 1996, TODAYS LIFE SCI, V10, P22
  • [4] Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney blood bank cohort patients infected with nef-defective HIV type 1
    Dyer, WB
    Ogg, GS
    Demoitie, MA
    Jin, X
    Geczy, AF
    Rowland-Jones, SL
    McMichael, AJ
    Nixon, DF
    Sullivan, JS
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (01) : 436 - 443
  • [5] Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription
    Estable, MC
    Bell, B
    Hirst, M
    Sadowski, I
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (08) : 6465 - 6474
  • [6] LONG-TERM SYMPTOMLESS HIV-1 INFECTION IN RECIPIENTS OF BLOOD PRODUCTS FROM A SINGLE DONOR
    LEARMONT, J
    TINDALL, B
    EVANS, L
    CUNNINGHAM, A
    CUNNINGHAM, P
    WELLS, J
    PENNY, R
    KALDOR, J
    COOPER, DA
    [J]. LANCET, 1992, 340 (8824) : 863 - 867
  • [7] Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1 - A report from the Sydney Blood Bank Cohort
    Learmont, JC
    Geczy, AF
    Mills, J
    Ashton, LJ
    Raynes-Greenow, CH
    Garsia, RJ
    Dyer, WB
    McIntyre, L
    Oelrichs, RB
    Rhodes, DI
    Deacon, NJ
    Sullivan, JS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (22) : 1715 - 1722
  • [8] HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
    Migueles, SA
    Sabbaghian, MS
    Shupert, WL
    Bettinotti, MP
    Marincola, FM
    Martino, L
    Hallahan, CW
    Selig, SM
    Schwartz, D
    Sullivan, J
    Connors, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) : 2709 - 2714
  • [9] Genomic sequence of HIV type 1 from four members of the Sydney Blood Bank Cohort of long-term nonprogressors
    Oelrichs, R
    Tsykin, A
    Rhodes, D
    Solomon, A
    Ellett, A
    McPhee, D
    Deacon, N
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (09) : 811 - 814
  • [10] Identification of a new recipient in the Sydney Blood Bank Cohort: A long-term HIV type 1-infected seroindeterminate individual
    Rhodes, D
    Solomon, A
    Bolton, W
    Wood, J
    Sullivan, J
    Learmont, J
    Deacon, N
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (16) : 1433 - 1439